Johnson & Johnson Robotics and Digital Solutions

Johnson & Johnson Innovation is a center for science and business experts to collaborate with innovators to incorporate science into healthcare solutions, including medical device and diagnostic technologies, consumer healthcare products, and pharmaceuticals. It is focused on the advancement of new healthcare solutions in the consumer, pharmaceutical, and medical devices and diagnostics sectors.’

The company provides financing tools that include early-stage research funding, seed funding, equity investments, licensing, and collaborations. Additionally, it offers its partners access to international markets, pricing and reimbursement, market testing, company creation services, and more. They conduct their activities with the help of regional incubators, satellite operations, single bench tops, modular labs, office space for entrepreneurs, and a year-round curriculum focused on business and drug development.

Johnson & Johnson Innovation is a subsidiary of Johnson & Johnson and its centers are located in Boston, California, London, and Shanghai.

Johnson & Johnson Robotics and Digital Solutions, established in 1973 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed investments across Biotechnology, Health Care, Medical, Therapeutics, Diabetes, Pharmaceutical, Manufacturing, Mobile, Medical Device, Health Diagnostics. The organization boasts a portfolio of 77 investments, with an average round size of $39.3M and 17 successful exits. Their recent investments include ViaCyte, Janssen, Binx Health, Novartis Venture Fund, BB Biotech Ventures. The highest investment round they participated in was $261.5B. Among their most notable exits are ViaCyte and Janssen. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.